News & Presentations Filter by Category All 59 Company News 21 Media 14 Newsletter 7 Presentations & Webinars 18 Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More Media, All Michelle Long 5/12/24 Media, All Michelle Long 5/12/24 Dr Michael Baker interviewed on the Marcus Today podcast Read More Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More Presentations & Webinars, All Michelle Long 29/10/24 Presentations & Webinars, All Michelle Long 29/10/24 AusBioInvest presentation Read More Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More Media, All Michelle Long 22/10/24 Media, All Michelle Long 22/10/24 Dr Michael Baker interviewed by JustStocks Read More Presentations & Webinars, All Michelle Long 16/10/24 Presentations & Webinars, All Michelle Long 16/10/24 Investor Presentation Read More Company News, All Michelle Long 14/10/24 Company News, All Michelle Long 14/10/24 Clinical Advisory Board established Read More Presentations & Webinars, All Michelle Long 23/9/24 Presentations & Webinars, All Michelle Long 23/9/24 Spark Plus Australian Equities Day presentation Read More Presentations & Webinars, All Michelle Long 18/9/24 Presentations & Webinars, All Michelle Long 18/9/24 September Investor Webinar recording Read More Company News, All Michelle Long 16/9/24 Company News, All Michelle Long 16/9/24 GO LIME! For Lymphoma this September Read More Presentations & Webinars, All Michelle Long 10/9/24 Presentations & Webinars, All Michelle Long 10/9/24 ALA presents at Cell and Gene Therapy World Asia Conference Read More Company News, All Michelle Long 3/9/24 Company News, All Michelle Long 3/9/24 Arovella added to the MSCI Global Micro Cap Index Read More Media, All Michelle Long 2/9/24 Media, All Michelle Long 2/9/24 Dr Michael Baker interview with The Stock Network Read More Newsletter, All Michelle Long 28/8/24 Newsletter, All Michelle Long 28/8/24 Arovella Newsletter August 2024 Read More Media, All Michelle Long 12/8/24 Media, All Michelle Long 12/8/24 Biotech Daily: Dr Boreham's Crucible: Arovella Read More Company News, All Michelle Long 7/8/24 Company News, All Michelle Long 7/8/24 Positive pre-IND feedback from FDA for ALA-101 Read More Older Posts
Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More
Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More
Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More
Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More
Media, All Michelle Long 5/12/24 Media, All Michelle Long 5/12/24 Dr Michael Baker interviewed on the Marcus Today podcast Read More
Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More
Presentations & Webinars, All Michelle Long 29/10/24 Presentations & Webinars, All Michelle Long 29/10/24 AusBioInvest presentation Read More
Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More
Media, All Michelle Long 22/10/24 Media, All Michelle Long 22/10/24 Dr Michael Baker interviewed by JustStocks Read More
Presentations & Webinars, All Michelle Long 16/10/24 Presentations & Webinars, All Michelle Long 16/10/24 Investor Presentation Read More
Company News, All Michelle Long 14/10/24 Company News, All Michelle Long 14/10/24 Clinical Advisory Board established Read More
Presentations & Webinars, All Michelle Long 23/9/24 Presentations & Webinars, All Michelle Long 23/9/24 Spark Plus Australian Equities Day presentation Read More
Presentations & Webinars, All Michelle Long 18/9/24 Presentations & Webinars, All Michelle Long 18/9/24 September Investor Webinar recording Read More
Company News, All Michelle Long 16/9/24 Company News, All Michelle Long 16/9/24 GO LIME! For Lymphoma this September Read More
Presentations & Webinars, All Michelle Long 10/9/24 Presentations & Webinars, All Michelle Long 10/9/24 ALA presents at Cell and Gene Therapy World Asia Conference Read More
Company News, All Michelle Long 3/9/24 Company News, All Michelle Long 3/9/24 Arovella added to the MSCI Global Micro Cap Index Read More
Media, All Michelle Long 2/9/24 Media, All Michelle Long 2/9/24 Dr Michael Baker interview with The Stock Network Read More
Newsletter, All Michelle Long 28/8/24 Newsletter, All Michelle Long 28/8/24 Arovella Newsletter August 2024 Read More
Media, All Michelle Long 12/8/24 Media, All Michelle Long 12/8/24 Biotech Daily: Dr Boreham's Crucible: Arovella Read More
Company News, All Michelle Long 7/8/24 Company News, All Michelle Long 7/8/24 Positive pre-IND feedback from FDA for ALA-101 Read More
